Liquid biopsies have emerged as a practical tool for genotyping circulating tumor DNA (ctDNA) in plasma. In patients with newly diagnosed NSCLC, knowledge of molecular alterations is essential for treatment decision-making.
Read More
Welcome to Sage Perspectives. Browse the latest posts below or explore the categories. Interested in writing for us? Get in touch and let us know your ideas.
Liquid biopsies have emerged as a practical tool for genotyping circulating tumor DNA (ctDNA) in plasma. In patients with newly diagnosed NSCLC, knowledge of molecular alterations is essential for treatment decision-making.
Read More